GlassScriptPhysician profile
Shin Lee
NPI 1255903795
$2,565.55
in general payments reported to CMS, 2019-2025
15 companies · $687 in 2025
The $687 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $492 · 2023: $690 · 2024: $696 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,073.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $506.57 | 2022-2025 | Tryptyr, Rocklatan, Clareon |
| Abbvie INC. | $442.18 | 2022-2025 | |
| Oyster Point Pharma, INC. | $380.71 | 2022-2024 | Tyrvaya, Ryzumvi, Tyrvaya |
| Sun Pharmaceutical Industries INC. | $331.33 | 2023-2025 | Cequa |
| Harrow Eye, LLC | $201.39 | 2024-2025 | Vevye, Zerviate |
| Mallinckrodt Hospital Products INC. | $146.53 | 2022-2025 | Acthar |
| Bausch & Lomb Americas INC. | $133.16 | 2023-2025 | Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $116.79 | 2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $93.12 | 2022 | |
| Thea Pharma INC. | $85.82 | 2023-2025 | Iyuzeh |
| Glaukos Corporation | $45.25 | 2022-2024 | Radius |
| Dompe US, INC. | $27.15 | 2025 | Oxervate |
| Krystal Biotech INC | $24.03 | 2024 | Vyjuvek |
| Sight Sciences, INC. | $16.54 | 2024 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $14.98 | 2025 | Tecnis Iol, Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.